These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13406048)

  • 1. Incorporation of N15-L-aspartic acid into the abnormal serum and urine proteins of multiple myeloma; studies of the inter-relationship of these proteins.
    OSSERMAN EF; GRAFF A; MARSHALL M; LAWLOR D; GRAFF S
    J Clin Invest; 1957 Feb; 36(2):352-60. PubMed ID: 13406048
    [No Abstract]   [Full Text] [Related]  

  • 2. Turnover rate of myeloma proteins in serum and urine determined after intravital labelling with glycine--1--C--14.
    DRIVSHOLM A
    Acta Med Scand; 1961 May; 169():503-7. PubMed ID: 13724428
    [No Abstract]   [Full Text] [Related]  

  • 3. An electrophoretic study of the abnormal proteins in urine, peripheral venous and bone marrow sera in multiple myeloma.
    JIM RT
    Blood; 1957 Jan; 12(1):56-63. PubMed ID: 13382989
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteins in multiple myeloma. VIII. Biosynthesis of abnormal proteins.
    PUTNAM FW; MIYAKE A
    J Biol Chem; 1958 Apr; 231(2):671-84. PubMed ID: 13539002
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary observations on difference in carbohydrate binding between abnormal serum and urine proteins of multiple myeloma.
    OSSERMAN EF; LAWLOR DP
    Science; 1954 Oct; 120(3122):715-6. PubMed ID: 13205216
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrophoretic research on the plasmatic and urinary proteins in multiple myeloma].
    GASTALDI F; RODARI T; CERESA G
    Rass Fisiopatol Clin Ter; 1961 Jul; 33():551-72. PubMed ID: 13897203
    [No Abstract]   [Full Text] [Related]  

  • 7. The biological significance of the anomalous serum and urinary proteins of myelomatosis, lymphoma, and other conditions.
    OWEN JA; GOT C
    J Clin Pathol; 1960 Jan; 13(1):58-68. PubMed ID: 14429550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathological protein synthesis in myeloma. (Chemical, chemico-physical and immunological aspects)].
    MAIORCA R; SCARPIONI L
    Rass Fisiopatol Clin Ter; 1960 Dec; 32():1173-225. PubMed ID: 13765490
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteins in multiple myeloma. IV. Interaction with metabolic nitrogen.
    HARDY S; PUTNAM FW
    J Biol Chem; 1955 Jan; 212(1):371-8. PubMed ID: 13233239
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of M protein by mouse myeloma tumor: correlation of in vitro and in vivo methods.
    TRUAX WE; BRAY JP
    Blood; 1961 Aug; 18():176-81. PubMed ID: 13778228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of calcium and phosphate metabolism in multiple myeloma].
    SCHMUZIGER P; FLURY R
    Schweiz Med Wochenschr; 1962 Sep; 92():1085-90. PubMed ID: 13908868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aspects of iron metabolism in multiple myeloma, examined with radioactive iron].
    FRANCKE C; HARDERS CL; VAN MULKEN JM; ROBERT WN
    Ned Tijdschr Geneeskd; 1954 Nov; 98(47):3377-83. PubMed ID: 13223880
    [No Abstract]   [Full Text] [Related]  

  • 13. F Fate of radiosulfate in multiple myeloma.
    SIEGEL E; SACHS BA; GRAIG FA
    Proc Soc Exp Biol Med; 1959 May; 101(1):53-6. PubMed ID: 13658188
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential expression of HOXB7 gene in multiple myeloma and extramedullary multiple myeloma patients.
    Novak EM; Linardi C; Metzger M; Maria DA; Giorgi RR; Moura F; Martinez GA; Bydlowski SP
    Eur J Haematol; 2010 Feb; 84(2):185-6. PubMed ID: 19878270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical and immunological findings of multiple myeloma].
    Asaoku H
    Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma with discordant M components in the serum and CSF.
    Dotten DA; Pruzanski W
    Arch Intern Med; 1981 Sep; 141(10):1374-6. PubMed ID: 6791605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between pathological and normal protein synthesis in Kahler's disease].
    TEN THIJE OJ
    Ned Tijdschr Geneeskd; 1955 Nov; 99(47):3558-60. PubMed ID: 13288640
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolism of DL-glutamic acid-1-C14 in man.
    PUTNAM FW; MIYAKE A; MEYER F
    J Biol Chem; 1958 Apr; 231(2):657-69. PubMed ID: 13539001
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.